The Ludwig institute for cancer research Melbourne melanoma cell line panel

Pigment Cell and Melanoma Research

Volumn 26, Issue 4, 2013, Pages 597-600

  Behren, Andreas ^a   Anaka, Matthew ^a   Lo, Pu Han ^a   Vella, Laura J ^a   Davis, Ian D ^c   Catimel, Jenny ^a   Cardwell, Tracy ^a   Gedye, Craig ^b   Hudson, Christopher ^a   Stan, Rodica ^a   Cebon, Jonathan ^a  

^a AUSTIN HOSPITAL   (Australia)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c EASTERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CANCER VACCINE; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MELAN A; MELANOMA ANTIGEN; MEMBRANE PROTEIN; MONOPHENOL MONOOXYGENASE; PREMELANOSOME PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER IMMUNOTHERAPY; CANCER RESEARCH; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA CELL; MUTANT; MYCOPLASMA; NONHUMAN; PROTEIN EXPRESSION; TREATMENT FAILURE;

ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CLUSTER ANALYSIS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA ANTIGENS; HUMANS; MALE; MELANOMA; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 84879780297     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12097     Document Type: Article

References (12)

1. Anaka, M., Freyer, C., Gedye, C., Caballero, O., Davis, I.D., Behren, A., and Cebon, J. (2012). Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile. Stem Cells 30, 336-343.
2. Caballero, O.L., and Chen, Y.T. (2009). Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100, 2014-2021.
3. Chapman, P.B., Hauschild, A., Robert, C. et al. (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507-2516.
4. Damsky, W.E., and Bosenberg, M. (2012). From bedding to bedside: genetically engineered mouse models of cancer inform concurrent clinical trials. Pigment Cell Melanoma. Res. 25, 404-405.
5. Dimopoulos, N., Jackson, H.M., Ebert, L., Guillaume, P., Luescher, I.F., Ritter, G., and Chen, W. (2009). Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells. J. Immunol. Methods 340, 90-94.
6. Ebert, L.M., Tan, B.S., Browning, J. et al. (2008). The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res. 68, 3001-3009.
7. Ebert, L.M., Liu, Y.C., Clements, C.S. et al. (2009). A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. Cancer Res. 69, 1046-1054.
8. Gedye, C., Quirk, J., Browning, J., Svobodova, S., John, T., Sluka, P., Dunbar, P.R., Corbeil, D., Cebon, J., and Davis, I.D. (2009). Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. Cancer Immunol. Immunother. 58, 1635-1646.
9. Hodi, F.S., O'day, S.J., Mcdermott, D.F. et al. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723.
10. Smyth, G.K.(2005). Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber, eds. (New York, NY: Springer) pp 397-420 (Publisher web site, PDF).
11. Tan, B., Behren, A., Anaka, M., Vella, L., Cebon, J., Mariadason, J.M., and Chen, W. (2012). FOXP3 is not mutated in human melanoma. Pigment Cell Melanoma. Res. 25, 398-400.
12. Zhao, R.Y., Mifsud, N.A., Xiao, K. et al. (2012). A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen. PLoS ONE 7, e44707.